Shao P. Chen

Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells.

Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells.

Journal: Frontiers in cell and developmental biology

Published: March 08, 2021

Correction: Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.

Correction: Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.

Journal: Cell death & disease

Published: July 02, 2020

Expression of HPV16 E6 recombinant protein and preparation of its rabbit polyclonal antibody

Expression of HPV16 E6 recombinant protein and preparation of its rabbit polyclonal antibody

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: May 12, 2020

Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.

Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.

Journal: Cell death & disease

Published: October 09, 2019

Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma.

Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma.

Journal: PLoS pathogens

Published: June 18, 2019

A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer.

A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer.

Journal: Theranostics

Published: December 27, 2017

Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model.

Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model.

Journal: Vaccine

Published: September 28, 2016

Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.

Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.

Journal: Oncotarget

Published: September 15, 2015

Mutagenicity of ZnO nanoparticles in mammalian cells: Role of physicochemical transformations under the aging process.

Mutagenicity of ZnO nanoparticles in mammalian cells: Role of physicochemical transformations under the aging process.

Journal: Nanotoxicology

Published: February 14, 2015

Chimerically fused antigen rich of overlapped epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a potential vaccine and diagnostic agent.

Chimerically fused antigen rich of overlapped epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a potential vaccine and diagnostic agent.

Journal: Cellular & molecular immunology

Published: June 23, 2014

A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice.

A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice.

Journal: Acta biochimica et biophysica Sinica

Published: April 01, 2014

Expression of HPV16 E7 protein and preparation of its polyclonal antibody

Expression of HPV16 E7 protein and preparation of its polyclonal antibody

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: February 05, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026